Clinical trial · Observational
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975CI-TRIAL-00112921BESTrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Research into biomarkers predictive of survival and response to cancer treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood sampling | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- principal
- description
- blood sampling
- interventionNames
- Other: blood sampling
Primary outcomes (1)
- measure
- Prediction
- timeFrame
- day 1
- description
- The aim of this project is to make a biobank in prevision of MR004 sub-projects which define specific biomarkers studied to identify biomarkers predictive of response.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care, * Patient who has read the information note and stated that he/she has no objections * Patient who has not objected to the use of this data for medical research purposes * Patient with social security cover. Exclusion Criteria: * Patient already included in the study * Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8
References
Publications (0)
Data not yet available
No reference posted for this study.